Phio Pharmaceuticals Corp.
PHIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $136 | $11 | $0 | $14 |
| - Cash | $11 | $11 | $13 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $125 | $0 | -$13 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.44 | -0.45 | -41,070.15 | -0.37 |
| % Growth | 2.2% | 100% | -11,099,940.5% | – |
| Operating Cash Flow | -$2 | -$3 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$3 | -$1 | -$1 |